Glaxo Accelerates Ebola Vaccine

The video discusses various company updates. Adidas shares rise due to speculation about a Reebok sale to a Hong Kong and Abu Dhabi investment group. Philips shares fall after missing earnings estimates, affected by weak demand in Russia and China. SAP reports lower profits and cuts its forecast as it shifts towards cloud technology. GlaxoSmithKline accelerates the development of an Ebola vaccine, with trials underway in the UK, US, and Mali, aiming for vaccinations in West Africa if successful.

What is the speculated value of the bid for the Reebok unit?

• €3.0 billion

• €1.2 billion

• €2.5 billion

• €1.7 billion

Which two regions contributed to Philips' sluggish demand?

• North America and South America

• Russia and China

• Europe and Africa

• Australia and India

What strategic shift did SAP make that affected its earnings forecast?

• Investing in renewable energy

• Focusing on hardware sales

• Expanding into retail markets

• Shifting towards web-based software solutions

What is the primary goal of GlaxoSmithKline's accelerated vaccine development?

• To treat COVID-19

• To treat influenza

• To treat Ebola

• To treat malaria

In which countries could vaccinations begin if GlaxoSmithKline's trials are successful?

• Guinea, Liberia, and Sierra Leone

• Nigeria, Kenya, and South Africa

• Brazil, Argentina, and Chile

• India, Pakistan, and Bangladesh